查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426980

流感诊断测试市场- 按测试类型（传统诊断测试{RIDT、DFAT、病毒培养、血清学测定}、分子诊断测定{RT-PCR、LAMP、NASBAT、SAMBA}）、最终用途和预测，2023 年- 2032年

Influenza Diagnostic Tests Market - By Test Type (Traditional Diagnostic Test {RIDT, DFAT, Viral Culture, Serological Assay}, Molecular Diagnostic Assay {RT-PCR, LAMP, NASBAT, SAMBA}), End-use & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

由于全球流感反覆爆发，凸显了对准确、快速诊断解决方案的迫切需求，预计 2023 年至 2032 年间，流感诊断测试市场的CAGR将达到 6.3%。根据世界卫生组织 2023 年 10 月的报告，每年约有 10 亿例季节性流感病例，其中包括 300-500 万例重症病例。当全世界都在努力应对流感的持续威胁时，诊断测试有助于早期发现、有效治疗和遏制病毒。

诊断工具的不断发展，包括分子检测、快速抗原检测和核酸扩增技术，提高了流感诊断的精确度和效率。对更灵敏、更特异和更快速的诊断方法的追求鼓励了研发投资。

流感诊断测试产业根据测试类型、最终用途和地区进行细分。

分子诊断分析领域有望在预测期内大幅增长，因为聚合酶链反应（PCR）和核酸扩增测试在检测流感病毒方面具有高灵敏度和特异性。这种精确度对于准确和及时的诊断非常重要，可以迅速启动适当的治疗和遏制措施。对快速、可靠的诊断解决方案的需求不断增长，加上分子诊断技术的进步，促进了该领域的成长。

由于在推进诊断技术和方法方面发挥重要作用，研究实验室部门将在 2023 年至 2032 年期间为市场带来可观的收入。研究实验室帮助开发创新的诊断方法和不断改进现有的测试平台。研究实验室对卓越诊断准确性的追求直接转化为更可靠、更有效率的测试的可用性，从而提高了诊断能力的整体标准。

由于快速的城市化、医疗保健意识的提高以及政府积极主动对抗传染病，亚太地区流感诊断测试行业预计到 2032 年将显着增长。流感发生率的增加，加上人们对传染病的经济影响的认识不断提高，刺激了对精确诊断解决方案的需求。此外，医疗机构、政府和诊断公司之间的策略合作有助于更有效地应对流感疫情，有利于区域市场前景。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：流感诊断测试产业见解

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 流感流行率不断上升
      • 快速诊断测试的需求增加
      • 技术进步
      • 研发活动增加
    • 产业陷阱与挑战
      • 测试敏感性和特异性的差异
      • 严格的监管指引
  • 成长潜力分析
  • COVID-19 影响分析
  • 监管环境
  • 报销场景
  • 技术景观
  • 缺口分析
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 供应商矩阵分析
  • 战略仪表板

第 5 章：流感诊断测试市场规模与预测：按测试类型

  • 主要测试类型趋势
  • 传统诊断测试
    • 流感快速诊断检测 (RIDT)
    • 直接萤光抗体检验（DFAT）
    • 病毒培养
    • 血清学检测
  • 分子诊断分析
    • 逆转录聚合酶连锁反应
    • 基于环介导等温扩增的测定 (LAMP)
    • 基于核酸序列的扩增检验 (NASBAT)
    • 基于简单扩增的测定 (SAMBA)
    • 其他分子诊断测定

第 6 章：流感诊断测试市场规模与预测：依最终用途

  • 主要最终用途趋势
  • 医院
  • 诊断中心
  • 研究实验室
  • 其他最终用户

第 7 章：流感诊断测试市场规模与预测：按地区

  • 主要区域趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • MEA 的其余部分

第 8 章：公司简介

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Becton, Dickinson and Company
  • Coris BioConcept
  • DiaSorin SpA
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Sekisui Diagnostics
  • Thermo Fischer Scientific Inc.
  • Hologic Inc.
Product Code: 4242

Influenza Diagnostic Tests Market is estimated to witness 6.3% CAGR between 2023 and 2032, owing to the recurrent global outbreaks of influenza that highlight the critical need for accurate and rapid diagnostic solutions. As per WHO October 2023 report, there were approximately a billion cases of seasonal influenza annually, which included 3-5 million cases of severe illness. As the world grapples with the ongoing threat of influenza, diagnostic tests help in early detection, effective treatment, and containment of the virus.

The continual evolution of diagnostic tools, including molecular assays, rapid antigen tests, and nucleic acid amplification techniques, enhances the precision and efficiency of influenza diagnosis. The quest for more sensitive, specific, and quicker diagnostic methods encourages R&D investments.

Influenza diagnostic tests industry is segmented on the basis of test type, end-use, and region.

Molecular diagnostic assays segment is poised for substantial growth over the forecast period, as polymerase chain reaction (PCR) and nucleic acid amplification tests, offer high sensitivity and specificity in detecting influenza viruses. This precision is important for accurate and timely diagnosis, allowing for prompt initiation of appropriate treatments and containment measures. The growing demand for rapid and reliable diagnostic solutions, coupled with advancements in molecular diagnostic technologies, contribute to the segment growth.

Research laboratories segment will generate notable revenues for the market during 2023-2032, owing to the instrumental role in advancing diagnostic technologies and methodologies. Research laboratories help in the development of innovative diagnostic assays and the continual improvement of existing testing platforms. The pursuit of excellence in diagnostic accuracy within research laboratories directly translates into the availability of more reliable and efficient tests, elevating the overall standard of diagnostic capabilities.

Asia Pacific influenza diagnostic tests industry is slated to witness a significant growth rate through 2032, attributed to rapid urbanization, increased healthcare awareness, and proactive government initiatives to combat infectious disease. The increasing incidence of influenza, coupled with a rising awareness of the economic impact of infectious diseases, fuels the demand for precise diagnostic solutions. Moreover, strategic collaborations between healthcare institutions, governments, and diagnostic companies contribute to a more efficient response to influenza outbreaks, favoring the regional market outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & working
    • 1.2.1 Data collection
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Influenza diagnostic tests industry 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Regional trends
  • 2.4 Test type trend
  • 2.5 End-use trends

Chapter 3 Influenza Diagnostic Tests Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of influenza
      • 3.2.1.2 Rise in demand for rapid diagnostic tests
      • 3.2.1.3 Technological advancements
      • 3.2.1.4 Increase in R&D activities
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Variabilities in test sensitivity and specificity
      • 3.2.2.2 Stringent regulatory guidelines
  • 3.3 Growth potential analysis
    • 3.3.1 By test type
    • 3.3.2 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
  • 3.8 GAP analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company market share analysis, 2022
  • 4.4 Competitive positioning matrix
  • 4.5 Vendor matrix analysis
  • 4.6 Strategy dashboard, 2022

Chapter 5 Influenza Diagnostic Tests Market Size and Forecast, By Test Type (USD Million)

  • 5.1 Key test type trends
  • 5.2 Traditional diagnostic test
    • 5.2.1 Rapid influenza diagnostic test (RIDT)
    • 5.2.2 Direct fluorescent antibody test (DFAT)
    • 5.2.3 Viral culture
    • 5.2.4 Serological assay
  • 5.3 Molecular diagnostic assay
    • 5.3.1 RT-PCR
    • 5.3.2 Loop-mediated isothermal amplification-based Assay (LAMP)
    • 5.3.3 Nucleic acid sequence-based amplification test (NASBAT)
    • 5.3.4 Simple amplification-based assay (SAMBA)
    • 5.3.5 Other molecular diagnostic assays

Chapter 6 Influenza Diagnostic Tests Market Size and Forecast, By End-use (USD Million)

  • 6.1 Key end-use trends
  • 6.2 Hospitals
  • 6.3 Diagnostics centers
  • 6.4 Research laboratories
  • 6.5 Other end-users

Chapter 7 Influenza Diagnostic Tests Market Size and Forecast, By Region (USD Million)

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

  • 8.1 F. Hoffmann-La Roche Ltd
  • 8.2 Abbott
  • 8.3 Becton, Dickinson and Company
  • 8.4 Coris BioConcept
  • 8.5 DiaSorin SpA
  • 8.6 Meridian Bioscience Inc.
  • 8.7 Quidel Corporation
  • 8.8 Sekisui Diagnostics
  • 8.9 Thermo Fischer Scientific Inc.
  • 8.10 Hologic Inc.

Data Tables

  • TABLE 1. Product mapping
  • TABLE 2. Market revenue, by test type (2022)
  • TABLE 3. Market revenue, by end-use (2022)
  • TABLE 4. Market share, by region (2022)
  • TABLE 5. Competitive positioning matrix
  • TABLE 6. Vendor matrix analysis
  • TABLE 7. Traditional diagnostic test market size, 2018 - 2024 (USD Million)
  • TABLE 8. Traditional diagnostic test market size, 2025 - 2032 (USD Million)
  • TABLE 9. Rapid influenza diagnostic test (RIDT) market size, 2018 - 2024 (USD Million)
  • TABLE 10. Rapid influenza diagnostic test (RIDT) market size, 2025 - 2032 (USD Million)
  • TABLE 11. Direct fluorescent antibody test (DFAT) market size, 2018 - 2024 (USD Million)
  • TABLE 12. Direct fluorescent antibody test (DFAT) market size, 2025 - 2032 (USD Million)
  • TABLE 13. Viral culture market size, 2018 - 2024 (USD Million)
  • TABLE 14. Viral culture market size, 2025 - 2032 (USD Million)
  • TABLE 15. Hospital market size, 2018 - 2024 (USD Million)
  • TABLE 16. Hospital market size, 2025 - 2032 (USD Million)
  • TABLE 17. Assisted living market size, 2018 - 2024 (USD Million)
  • TABLE 18. Assisted living market size, 2025 - 2032 (USD Million)
  • TABLE 19. Serological assay market size, 2018 - 2024 (USD Million)
  • TABLE 20. Serological assay market size, 2025 - 2032 (USD Million)
  • TABLE 21. Molecular diagnostic assay market size, 2018 - 2024 (USD Million)
  • TABLE 22. Molecular diagnostic assay market size, 2025 - 2032 (USD Million)
  • TABLE 23. RT-PCR market size, 2018 - 2024 (USD Million)
  • TABLE 24. RT-PCR market size, 2025 - 2032 (USD Million)
  • TABLE 25. Loop-mediated isothermal amplification-based assay (LAMP) market size, 2018 - 2024 (USD Million)
  • TABLE 26. Loop-mediated isothermal amplification-based assay (LAMP) market size, 2025 - 2032 (USD Million)
  • TABLE 27. Nucleic acid sequence-based amplification test (NASBAT) market size, 2018 - 2024 (USD Million)
  • TABLE 28. Nucleic acid sequence-based amplification test (NASBAT) market size, 2025 - 2032 (USD Million)
  • TABLE 29. Simple amplification-based Assay (SAMBA) years market size, 2018 - 2024 (USD Million)
  • TABLE 30. Simple amplification-based Assay (SAMBA) years market size, 2025 - 2032 (USD Million)
  • TABLE 31. Other molecular diagnostic assays market size, 2018 - 2024 (USD Million)
  • TABLE 32. Other molecular diagnostic assays market size, 2025 - 2032 (USD Million)
  • TABLE 33. Hospitals years market size, 2018 - 2024 (USD Million)
  • TABLE 34. Hospitals years market size, 2025 - 2032 (USD Million)
  • TABLE 35. Diagnostics centers market size, 2018 - 2024 (USD Million)
  • TABLE 36. Diagnostics centers market size, 2025 - 2032 (USD Million)
  • TABLE 37. Research laboratories market size, 2018 - 2024 (USD Million)
  • TABLE 38. Research laboratories market size, 2025 - 2032 (USD Million)
  • TABLE 39. Other end-users market size, 2018 - 2024 (USD Million)
  • TABLE 40. Other end-users market size, 2025 - 2032 (USD Million)
  • TABLE 41. North America influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 42. North America influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 43. North America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 44. North America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 45. North America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 46. North America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 47. North America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 48. North America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 49. North America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 50. North America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 51. U.S. influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 52. U.S. influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 53. U.S. influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 54. U.S. influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 55. U.S. influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 56. U.S. influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 57. U.S. influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 58. U.S. influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 59. U.S. influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 60. U.S. influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 61. Canada influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 62. Canada influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 63. Canada influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 64. Canada influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 65. Canada influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 66. Canada influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 67. Canada influenza diagnostic tests market size, by payment source, 2018 - 2024, (USD Million)
  • TABLE 68. Canada influenza diagnostic tests market size, by payment source, 2025 - 2032, (USD Million)
  • TABLE 69. Canada influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 70. Canada influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 71. Europe influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 72. Europe influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 73. Europe influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 74. Europe influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 75. Europe influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 76. Europe influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 77. Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 78. Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 79. Europe influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 80. Europe influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 81. Germany influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 82. Germany influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 83. Germany influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 84. Germany influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 85. Germany influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 86. Germany influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 87. Germany influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 88. Germany influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 89. UK influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 90. UK influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 91. UK influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 92. UK influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 93. UK influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 94. UK influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 95. UK influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 96. UK influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 97. France influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 98. France influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 99. France influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 100. France influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 101. France influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 102. France influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 103. France influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 104. France influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 105. Spain influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 106. Spain influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 107. Spain influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 108. Spain influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 109. Spain influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 110. Spain influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 111. Spain influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 112. Spain influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 113. Italy influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 114. Italy influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 115. Italy influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 116. Italy influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 117. Italy influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 118. Italy influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 119. Italy influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 120. Italy influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 121. Rest of Europe influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 122. Rest of Europe influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 123. Rest of Europe influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 124. Rest of Europe influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 125. Rest of Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 126. Rest of Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 127. Rest of Europe influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 128. Rest of Europe influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 129. Asia Pacific influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 130. Asia Pacific influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 131. Asia Pacific influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 132. Asia Pacific influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 133. Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 134. Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 135. Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 136. Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 137. Asia Pacific influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 138. Asia Pacific influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 139. China influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 140. China influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 141. China influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 142. China influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 143. China influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 144. China influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 145. China influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 146. China influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 147. Japan influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 148. Japan influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 149. Japan influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 150. Japan influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 151. Japan influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 152. Japan influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 153. Japan influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 154. Japan influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 155. India influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 156. India influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 157. India influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 158. India influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 159. India influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 160. India influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 161. India influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 162. India influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 163. Australia influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 164. Australia influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 165. Australia influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 166. Australia influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 167. Australia influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 168. Australia influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 169. Australia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 170. Australia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 171. South Korea influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 172. South Korea influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 173. South Korea influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 174. South Korea influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 175. South Korea influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 176. South Korea influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 177. South Korea influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 178. South Korea influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 179. Rest of Asia Pacific influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 180. Rest of Asia Pacific influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 181. Rest of Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 182. Rest of Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 183. Rest of Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 184. Rest of Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 185. Rest of Asia Pacific influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 186. Rest of Asia Pacific influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 187. Latin America influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 188. Latin America influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 189. Latin America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 190. Latin America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 191. Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 192. Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 193. Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 194. Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 195. Latin America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 196. Latin America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 197. Brazil influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 198. Brazil influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 199. Brazil influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 200. Brazil influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 201. Brazil influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 202. Brazil influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 203. Brazil influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 204. Brazil influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 205. Mexico influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 206. Mexico influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 207. Mexico influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 208. Mexico influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 209. Mexico influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 210. Mexico influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 211. Mexico influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 212. Mexico influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 213. Argentina influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 214. Argentina influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 215. Argentina influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 216. Argentina influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 217. Argentina influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 218. Argentina influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 219. Argentina influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 220. Argentina influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 221. Rest of Latin America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 222. Rest of Latin America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 223. Rest of Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 224. Rest of Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 225. Rest of Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 226. Rest of Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 227. Rest of Latin America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 228. Rest of Latin America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 229. MEA influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 230. MEA influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 231. MEA influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 232. MEA influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 233. MEA influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 234. MEA influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 235. MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 236. MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 237. MEA influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 238. MEA influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 239. South Africa influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 240. South Africa influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 241. South Africa influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 242. South Africa influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 243. South Africa influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 244. South Africa influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 245. South Africa influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 246. South Africa influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 247. Saudi Arabia influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 248. Saudi Arabia influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 249. Saudi Arabia influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 250. Saudi Arabia influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 251. Saudi Arabia influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 252. Saudi Arabia influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 253. Saudi Arabia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 254. Saudi Arabia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 255. Saudi Arabia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 256. Saudi Arabia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 257. UAE influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 258. UAE influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 259. UAE influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 260. UAE influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 261. UAE influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 262. UAE influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 263. UAE influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 264. UAE influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 265. Rest of MEA influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 266. Rest of MEA influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 267. Rest of MEA influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 268. Rest of MEA influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 269. Rest of MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 270. Rest of MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 271. Rest of MEA influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 272. Rest of MEA influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Influenza diagnostic tests industry 360 degree synopsis, 2018 - 2032
  • FIG. 8 Industry ecosystem analysis
  • FIG. 9 Industry impact forces
  • FIG. 10 Growth potential analysis, by test type
  • FIG. 11 Growth potential analysis, by end-use
  • FIG. 12 GAP analysis
  • FIG. 13 Porter's analysis
  • FIG. 14 PESTEL analysis
  • FIG. 15 Company matrix analysis, 2022
  • FIG. 16 Global company market share analysis, 2022
  • FIG. 17 Competitive positioning matrix
  • FIG. 18 Strategy dashboard, 2022